Who are Biolumen's investors?

Biolumen's investors include Embryo Ventures.

How much funding has Biolumen raised?

Biolumen has disclosed $250K raised across 1 round.

Where is Biolumen headquartered?

Biolumen is headquartered in San Francisco, US.

Biolumen

San Francisco, US · Founded 2019 · Delaware corporation · 1 known investors

Find your way into Biolumen

254 people in our graph share verified history with the Biolumen team — schools, employers, funds. One of them is your warm intro.

Xavier Mesnierunlockedknows Gabriel Paulino · together at AgroParisTech (overlapped)

×5knows the team · via AgroParisTech

×4knows the team · via UC Berkeley Extension

knows the team · via University of California, San Francisco - School of Medicine

knows the team · via Sapienza Università di Roma

Biolumen is a biotech company focused on bioengineering for wellness, founded by a serial entrepreneur with expertise in biopolymers. The company appears to be developing food and beverage-related products leveraging bioengineering innovations.

Biotech FoodTech Wellness & Fitness

Founders & leadership

Paolo Costa inChief Executive OfficerCosta began his career in polymer laboratories at ItalPlastic and as lab chief for quality control at Soplastic Faaca before founding a series of companies, including Vispaav, Stile Italiano, Teratekne and Primigenia. From 2015 to 2018 he served as founder, president and CEO of Slendine AG, and he has led BioLumen as chief executive officer since 2020.

Gabriel Paulino inCo-Founder & Chief Executive Officer2019–2020Gabriel Paulino is President and CEO of Biolumen, a biotech company developing bioengineered products for wellness applications in food, beverage, and related sectors. He has background in agriculture, biochemistry, and business development across health tech and biotech industries.

Stefan PinterTreasurer

Investors · 1

Embryo VenturesLondon

Reported raises · per SEC filings

Form D private placements

$250K disclosed across 1 round · 2019

▶$250KraisedNov 2019 · 1 investors · Other

Rule 506(b)

Officers, directors & promoters on the filing

Paolo CostaExecutive Officer, Director, Promoter
Gabriel PaulinoExecutive Officer, Director, Promoter
Stefan PinterExecutive Officer, Director

Offering amount: $250K
Amount sold: $250K
First sale: Oct 2019
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 4

by search overlap

Lumen4 shared keywordsLumen develops orally delivered antibody drugs using engineered spirulina, a patented biologic platform that reduces manufacturing costs and timelines compared to conventional biologics. The company serves biopharma customers seeking alternatives to traditional drug manufacturing.

Morelumen3 shared keywordsMore Lumen produces Peaches & Cream, a dairy-free sparkling protein drink designed for consumers seeking clean nutrition without heavy texture or artificial ingredients. The product targets health-conscious individuals looking for convenient protein supplementation that fits into daily routines.

SOSV Visit SOSV3 shared keywordsSOSV is a venture capital firm that provides pre-seed funding (up to $550,000) to founders in deep technology sectors including life sciences, robotics, industrial automation, energy transition, and medical technology. The firm operates accelerator programs in New York City, San Francisco, and Newark, NJ, and does not invest in enterprise software, fintech, blockchain, crypto, cybersecurity, or ecommerce.

EquityZen3 shared keywordsEquityZen operates an online marketplace that gives accredited individual investors access to shares in late-stage private companies through secondary market transactions. Now part of Morgan Stanley, the platform provides private market data, offering documents, and guided investment processes for buying and selling pre-IPO equity.

Companies competing with Biolumen for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Biolumen do?: Biolumen is a biotech company focused on bioengineering for wellness, founded by a serial entrepreneur with expertise in biopolymers. The company appears to be developing food and beverage-related products leveraging bioengineering innovations.
Who are Biolumen's investors?: Biolumen's investors include Embryo Ventures.
How much funding has Biolumen raised?: Biolumen has disclosed $250K raised across 1 round.
Where is Biolumen headquartered?: Biolumen is headquartered in San Francisco, US.